About Emtora Biosciences
Emtora Biosciences is a company based in San Antonio (United States) founded in 2009.. Emtora Biosciences has raised $2.5 million across 5 funding rounds from investors including Metric Medical Devices, CPRIT and UT Horizon Fund. Emtora Biosciences offers products and services including eRapa. Emtora Biosciences operates in a competitive market with competitors including Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Nymox Pharmaceutical, among others.
- Headquarter San Antonio, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.5 M (USD)
in 5 rounds
-
Latest Funding Round
$16.9 M (USD), Grant
Aug 19, 2022
-
Investors
Metric Medical Devices
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emtora Biosciences
Emtora Biosciences offers a comprehensive portfolio of products and services, including eRapa. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Formulation of rapamycin for cancer and rare disease treatment.
Funding Insights of Emtora Biosciences
Emtora Biosciences has successfully raised a total of $2.5M across 5 strategic funding rounds. The most recent funding activity was a Grant round of $16.9 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $16.9M
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Grant - Emtora Biosciences | Valuation |
investors |
|
| Aug, 2019 | Amount | Grant - Emtora Biosciences | Valuation |
investors |
|
| Jun, 2015 | Amount | Series A - Emtora Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Emtora Biosciences
Emtora Biosciences has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Metric Medical Devices, CPRIT and UT Horizon Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Orthopedic implant systems for musculoskeletal fixation are developed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emtora Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Emtora Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emtora Biosciences Comparisons
Competitors of Emtora Biosciences
Emtora Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Radionetics, Hinova Pharmaceuticals, Convergent Therapeutics, Nuage Therapeutics and Nymox Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Peptide-targeted radiopharmaceuticals for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Develops small molecule based drug for multiple disease treatment
|
|
| domain | founded_year | HQ Location |
Cancer therapeutics are developed using dual-targeted radionuclide therapy.
|
|
| domain | founded_year | HQ Location |
Drugs are developed for intrinsically disordered protein targets.
|
|
| domain | founded_year | HQ Location |
Provides research and development of novel drugs and diagnostic products for the aging population
|
|
| domain | founded_year | HQ Location |
Translational glycobiology research on galectin-3 inhibitors is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emtora Biosciences
Frequently Asked Questions about Emtora Biosciences
When was Emtora Biosciences founded?
Emtora Biosciences was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Where is Emtora Biosciences located?
Emtora Biosciences is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
Is Emtora Biosciences a funded company?
Emtora Biosciences is a funded company, having raised a total of $2.5M across 5 funding rounds to date. The company's 1st funding round was a Series A of $2.5M, raised on Dec 01, 2012.
What does Emtora Biosciences do?
Emtora Biosciences is reformulating therapies for treating cancers and other age-related disorders. They have developed eRapa which is a formulation of rapamycin that can extend life by delaying the onset of aging-related diseases such as cancer. The lead candidate is in phase I clinical trial. It is being investigated for Familial Adenomatous Polyposis (a genetic condition that increases the risk of colon cancer).
Who are the top competitors of Emtora Biosciences?
Emtora Biosciences's top competitors include Radionetics, Nuage Therapeutics and Convergent Therapeutics.
What products or services does Emtora Biosciences offer?
Emtora Biosciences offers eRapa.
Who are Emtora Biosciences's investors?
Emtora Biosciences has 3 investors. Key investors include Metric Medical Devices, CPRIT, and UT Horizon Fund.